LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

Photo from wikipedia

Key Points • Currently, patients receive a single dose of tisagenlecleucel across a wide dose range.• Clinicians could choose to give a higher dose of tisagenlecleucel upfront, within the approved… Click to show full abstract

Key Points • Currently, patients receive a single dose of tisagenlecleucel across a wide dose range.• Clinicians could choose to give a higher dose of tisagenlecleucel upfront, within the approved dose range, to optimize response.

Keywords: doses tisagenlecleucel; improved outcomes; higher doses; tisagenlecleucel associated; outcomes report; associated improved

Journal Title: Blood Advances
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.